GEEL, Belgium, Sept. 16, 2020 /PRNewswire/ -- OCTIMET Oncology NV, a clinical-stage Belgian life science company with a focus on the development of highly selective, differentiated MET kinase ...
Role of ultrasound contrast agent in a tertiary cancer center: Experience in 75 patients with liver biopsy. Non-inferiority of a new advanced dry plasma thawing system compared to leading standard ...
Please note - this trial is no longer recruiting patients. We hope to add results when they are available. This study is for people who have an advanced solid tumour (particularly lung cancer). It is ...
OMO-1 has potential to treat cancer as a monotherapy and in combination with EGFR TKIs for patients becoming resistant to and progressing on treatment GEEL, Belgium, Sept. 16, 2020 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results